Pilot Usability Study to Set Up and Use the Feetsee™ Foot Monitoring Device in Adults With Diabetes
Starting soon
Conditions studied: Diabetes
In brief
Single-center, prospective, minimal-risk, non-experimental usability study assessing the setup and use of the FDA-registered (Class I medical device; 510(k)-exempt) Feetsee™ home foot-monitoring system by adults with diabetes in their home environment over 8 weeks. This study in non clinical, observational pilot usability study conducted under FDA Human Factors and Usability Engineering guidance (2016).
Key facts
- Study ID
- NCT07666087
- Run by
- Diabetis JSC
- People needed
- 20
- Starts
- 2026-07-10
- Expected to finish
- 2027-07-10
- Last updated by the study team
- 2026-06-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Males and females aged 18 years or older
- Clinical diagnosis of Type 1 or Type 2 diabetes
- At least one palpable foot pulse per feet
- Possess basic ability to use a smartphone or tablet
- Have no prior experience with the Feetsee™ system
- Be willing and able to provide informed consent
You may not qualify if…
- Active foot ulceration at enrollment
- Active Charcot neuro-osteoarthropathy
- Severe vascular disease (complete absence of foot pulses)
- Amputation of more than three toes
- Active malignancy or immunosuppressive condition
- Cognitive or physical impairments preventing proper device usage
- Concurrent participation in another investigational study with contraindicated procedures
Where it is running
- UT Health San Antonio — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.